Drug Pricing

There is growing public pressure to find an effective way to address the rising prices of prescription drugs. Multiple drug price bills await action in Congress and more than 80 bills have been introduced in state legislatures in 2017. Among the variety of approaches aimed at managing drug prices, importation from other countries is an […]

Read More
  • State Health Policy Blog

    With 80 bills introduced in 2017, there is a high level of interest in pharmaceutical pricing among state legislators. However, despite legislative sessions wrapping up, very few laws have been enacted. To date, bills have passed in Maryland, Montana, New Mexico, New York, and Utah. In 2016, Vermont led the way with a price transparency […]

    Read More
  • Pharmacy Costs Work Group – Model Legislation

    NASHP, with guidance from our Pharmacy Costs Work Group, has developed model legislation for states that wish to pursue the policy options outlined in our paper States and the Rising Costs of Pharmaceuticals: A Call to Action. States interested in this model legislation will have access to a legislator’s guide and additional background materials as […]

    Read More
  • Pharmaceutical prices are rising, driving up premiums and out of pocket costs. State budgets – that by law, have to be balanced- are reeling from high and unpredictable pharmaceutical price increases for Corrections, state employees and retirees, K-12 and public  university employees, and, of course,  Medicaid. To address rapidly rising prescription drug prices, purchasers and policy […]

    Read More
  • State Health Policy Blog

    Pharmaceutical prices are rising, driving up premiums and out-of-pocket costs. Today, 21 percent of spending in employer-sponsored plans goes to retail prescription drugs.[i] State budgets – that by law, have to be balanced- are reeling from high and unpredictable pharmaceutical increases for corrections, state employees and retirees, K-12 and public university employees, and, of course, […]

    Read More
  • State Health Policy Blog

    Congress has begun its Affordable Care Act (ACA) repeal effort and evolving replacement options are receiving considerable attention. NASHP is tracking issues that appear in multiple proposals and will provide state perspectives, including: How might they impact states? What might they cost? Have they been tried before in states and what did we learn from […]

    Read More
  • Webinars

    In this webinar, members of the National Academy for State Health Policy’s Pharmacy Costs Workgroup review 11 specific proposals for how states may curb the rising cost of pharmaceuticals. NASHP’s work group looks broadly at states as purchasers, regulators, policymakers, and investors to develop the next generation of state–based reforms to address the rapid growth […]

    Read More
  • States and the Rising Cost of Pharmaceuticals: A Call to Action
    Publications

    As part of the 29th Annual State Health Policy Conference, held 17-19 in Pittsburgh, PA, NASHP released findings from our Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals.  The solutions offered in the newly released findings serve as a toolbox for states. While they recognize the value of the pharmaceutical industry, state policymakers […]

    Read More
  • New Findings from Rx Work Group Released at National Health Event Pittsburgh, PA – The National Academy for State Health Policy (NASHP) today released findings from their Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals. The findings were released as part of their 29th Annual State Health Policy Conference, held […]

    Read More
  • State Legislative Action on Pharmaceutical Prices
    Maps

    *Updated November 3, 2017* As part of our Pharmacy Cost Work Group, an ongoing project that looks beyond the strategies currently used in states to identify and develop new ideas which address the growing problem of prescription drug costs, NASHP has been tracking state legislative actions to control the rising cost of prescription drugs. This series of […]

    Read More